Commonwealth Equity Services
IDNA icon

Commonwealth Equity Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Commonwealth Equity Services’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$804K Sell
27,668
-187
-0.7% -$5.43K ﹤0.01% 2796
2025
Q4 		$730K Sell
27,855
-336
-1% -$8.64K ﹤0.01% 2846
2025
Q3 		$666K Sell
28,191
-3,011
-10% -$66.6K ﹤0.01% 2946
2025
Q2 		$640K Buy
31,202
+490
+2% +$9.87K ﹤0.01% 2956
2025
Q1 		$629K Buy
30,712
+1,048
+4% +$23.4K ﹤0.01% 2846
2024
Q4 		$671K Sell
29,664
-5,225
-15% -$125K ﹤0.01% 2735
2024
Q3 		$859K Sell
34,889
-16,105
-32% -$392K ﹤0.01% 2466
2024
Q2 		$1.18M Sell
50,994
-59
-0.1% -$1.38K ﹤0.01% 2152
2024
Q1 		$1.23M Buy
51,053
+563
+1% +$13.2K ﹤0.01% 2102
2023
Q4 		$1.16M Sell
50,490
-1,607
-3% -$32.3K ﹤0.01% 2069
2023
Q3 		$1.06M Buy
52,097
+1,840
+4% +$41.3K ﹤0.01% 2033
2023
Q2 		$1.17M Buy
50,257
+2,417
+5% +$58K ﹤0.01% 1980
2023
Q1 		$1.11K Sell
47,840
-30,957
-39% -$774K ﹤0.01% 1971
2022
Q4 		$1.98M Sell
78,797
-23,370
-23% -$628K ﹤0.01% 1505
2022
Q3 		$2.7M Buy
102,167
+56,410
+123% +$1.74M 0.01% 1235
2022
Q2 		$1.32M Buy
45,757
+2,805
+7% +$83.7K ﹤0.01% 1684
2022
Q1 		$1.48M Buy
42,952
+20,868
+94% +$737K ﹤0.01% 1699
2021
Q4 		$967K Buy
22,084
+3,340
+18% +$158K ﹤0.01% 2014
2021
Q3 		$950K Buy
18,744
+1,061
+6% +$55.3K ﹤0.01% 1960
2021
Q2 		$920K Buy
17,683
+3,390
+24% +$159K ﹤0.01% 1974
2021
Q1 		$653K Buy
14,293
+4,002
+39% +$196K ﹤0.01% 2118
2020
Q4 		$472K Buy
10,291
+2,009
+24% +$86.7K ﹤0.01% 2187
2020
Q3 		$322K Buy
+8,282
New +$318K ﹤0.01% 2300

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Commonwealth Equity Services's IDNA Position: Q1 2026 in Review

Commonwealth Equity Services reduced its iShares Genomics Immunology and Healthcare ETF (IDNA) stake by 0.67% in Q1 2026, selling an estimated $5.43K and leaving 27,668 shares worth $804K. The position accounts for ﹤0.01% of the portfolio, ranked #2796.

Commonwealth Equity Services first reported a position in IDNA in Q3 2020 and has held it in 23 quarters since. The position peaked at $2.7M in Q3 2022. 60 funds tracked by Wall St. Rank hold IDNA as of Q1 2026.

  • Commonwealth Equity Services held 27,668 shares of iShares Genomics Immunology and Healthcare ETF worth $804K as of Q1 2026.
  • Commonwealth Equity Services sold 187 iShares Genomics Immunology and Healthcare ETF shares in Q1 2026, an estimated $5.43K.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #2796 holding.
  • Commonwealth Equity Services first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and has held it in 23 quarters since.
  • Commonwealth Equity Services's iShares Genomics Immunology and Healthcare ETF position peaked at $2.7M in Q3 2022.
  • 60 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.